Summary : The U.S. Food and Drug Administration approved Sanofi’s proposed drug to address red blood cell destruction in patients living with…
Sanofi
-
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
-
AgrochemicalsGlobal MarketSanofi Inc.
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
by adminby adminSynopsis : Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates…
-
AgrochemicalsGlobal MarketSanofi
Exscientia and Sanofi establish strategic Research collaboration to develop AI-Driven Pipeline of Precision-Engineered Medicines
by adminby adminHighlights : Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine…
-
Biocon PharmaceuticalCompanies
US Court Gives Favourable Order to Viatris Over Sanofi
by adminby adminSummary : -Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over…
-
AgrochemicalsSanofi Inc.
Sanofi’s Isatuximab Added to RVd Boosts Response in Multiple Myeloma
by adminby adminSummary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…